Intervention

Albuterol HFA MDI

ClinicalTrials.gov intervention label

Clinical trials3
Recruiting0
Common conditions1
Lead sponsors shown2

Clinical trials

3 shown
Safety and Pharmacokinetics of Halix(TM) Albuterol Unit Dose Disposable Inhaler Versus Albuterol MDINCT03373409 · 2017-11-30
COMPLETED
4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe AsthmaNCT00818454 · 2008-12-01
COMPLETED
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe AsthmaNCT00096616 · 2004-11-01
COMPLETED

Trial status mix

COMPLETED3

Phase mix

PHASE22
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.